SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-335270
Filing Date
2017-11-07
Accepted
2017-11-07 10:59:56
Documents
6
Period of Report
2017-11-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d490466d8k.htm 8-K 28876
2 EX-3.1 d490466dex31.htm EX-3.1 7549
3 EX-3.2 d490466dex32.htm EX-3.2 130355
4 EX-99.1 d490466dex991.htm EX-99.1 7637
5 GRAPHIC g471778g04b90.jpg GRAPHIC 3599
6 GRAPHIC g471778g77d44.jpg GRAPHIC 2973
  Complete submission text file 0001193125-17-335270.txt   185458
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37601 | Film No.: 171182188
SIC: 2836 Biological Products, (No Diagnostic Substances)